Clinical Trial Update: Apathy in Schizophrenia

View source ↗

Summary

INSERM-sponsored clinical trial studying apathy in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Schizophrenia, Apathy | Status: COMPLETED